GlassScriptPhysician profile
Trevor Ottofaro
NPI 1063917581
$7,365.09
in general payments reported to CMS, 2019-2025
10 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $223 · 2023: $1,574 · 2024: $3,903 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,177 · Food and Beverage: $2,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,177.40 |
| Food and Beverage | $2,839.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $2,418.88 | 2024 | |
| Stryker Corporation | $1,302.57 | 2024-2025 | Salvation, Variax, Inbone |
| Orthofix Medical, INC. | $845.70 | 2023-2025 | Truelok, Physio-Stim |
| Arthrex, INC. | $790.69 | 2023 | |
| Peerless Surgical INC. | $649.69 | 2021-2023 | |
| Medshape, INC. | $601.47 | 2024 | Dynanail Mini |
| Treace Medical Concepts, INC. | $287.91 | 2022-2025 | |
| Si-Bone, INC. | $239.18 | 2022-2023 | |
| Fortis Surgical, LLC | $202.78 | 2025 | |
| Paragon 28, INC. | $26.22 | 2024 | Apex 3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Ottofaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.